Cartesian Therapeutics, Inc. (RNAC) Earnings
|
Expand Research on RNAC
| Next EPS Date | 11/5/26 | EPS Growth Rate | +27.5% |
|---|---|---|---|
| Average EPS % Beat Rate | +38.1% | Revenue Growth Rate | -60.0% |
| Average % Move 1-Wk after EPS | +7.2% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/5/26  |
Q326 | N/A | -$1.00 | N/A | N/A | $180K | N/A | N/A | N/A | ||
| 8/6/26 | Q226 | $0.46 | -$0.88 | +$1.34 | N/A | $179.67K | N/A |  | | Details | |
| 4/30/26 | Q126 | -$1.46 | $0.00 | -$1.46 | N/A | N/A | N/A | | | Details | |
| 11/6/25 |
Q425 | N/A | -$0.90 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/6/25 | Q325 | -$1.38 | $0.00 | -$1.38 | $450K | N/A | N/A | | | Details | |
| 8/7/25 | Q225 | $0.50 | $0.00 | +$0.50 | $300K | N/A | N/A | | | Details | |
| 5/8/25 | Q125 | -$0.68 | $0.00 | -$0.68 | $1.1M | N/A | N/A | | | Details | |
| 8/8/24 | Q224 | $0.54 | -$0.90 | +$1.44 | $33.44M | $2.5M | N/A | | | Details |
